Alaa Al Hawamdeh, MD

Vancouver General Hospital · 1 session at 1 meeting · 1 upcoming

Topics

Long-Acting InjectablesOpioid Use Disorder

Sessions

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN · Full program

  • Poster48-Hour Transdermal Buprenorphine Induction to Initiate Extended-Release Buprenorphine for the Management of Opioid Use Disorder in an Outpatient setting: A Retrospective Case Series

    November 15, 2026, 08:00–09:30

    Case series on using transdermal buprenorphine over 48 hours to start extended-release buprenorphine in outpatients with OUD.

    Long-Acting InjectablesOpioid Use Disorder

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

Recurring meetings